HIC
NVO

Hartline Investment Corp’s Novo Nordisk NVO Stock Holding History

Hartline Investment Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,620
Closed -$231K – 103
2024
Q2 		$231K Sell
1,620
-15,754
-91% -$2.09M 0.03% 93
2024
Q1 		$2.23M Buy
+17,374
New +$2.07M 0.39% 49
2018
Q2 		– Sell
-139,244
Closed -$3.43M – 102
2018
Q1 		$3.43M Sell
139,244
-15,820
-10% -$415K 0.94% 28
2017
Q4 		$4.16M Sell
155,064
-5,650
-4% -$144K 1.15% 22
2017
Q3 		$3.87M Sell
160,714
-3,350
-2% -$75.7K 1.17% 20
2017
Q2 		$3.52M Sell
164,064
-2,850
-2% -$57.5K 1.12% 23
2017
Q1 		$2.86M Sell
166,914
-1,300
-0.8% -$22.6K 0.92% 33
2016
Q4 		$3.02M Sell
168,214
-29,390
-15% -$533K 1.05% 26
2016
Q3 		$4.11M Buy
197,604
+910
+0.5% +$22.6K 1.48% 14
2016
Q2 		$5.29M Sell
196,694
-2,120
-1% -$58.1K 1.9% 12
2016
Q1 		$5.39M Sell
198,814
-2,060
-1% -$55.2K 1.96% 9
2015
Q4 		$5.83M Buy
200,874
+24,484
+14% +$678K 2.18% 10
2015
Q3 		$4.78M Buy
176,390
+100
+0.1% +$2.83K 1.74% 15
2015
Q2 		$4.83M Sell
176,290
-3,150
-2% -$88.6K 1.61% 14
2015
Q1 		$4.79M Sell
179,440
-14,150
-7% -$326K 1.57% 17
2014
Q4 		$4.1M Buy
193,590
+720
+0.4% +$16.1K 1.37% 21
2014
Q3 		$4.59M Sell
192,870
-2,100
-1% -$48.3K 1.65% 12
2014
Q2 		$4.5M Sell
194,970
-24,350
-11% -$538K 1.62% 13
2014
Q1 		$5.01M Buy
219,320
+87,570
+66% +$1.87M 1.71% 11
2013
Q4 		$2.43M Sell
131,750
-1,000
-0.8% -$17.4K 0.85% 45
2013
Q3 		$2.25M Buy
132,750
+2,000
+2% +$33.6K 0.88% 44
2013
Q2 		$2.03M Buy
+130,750
New +$2.18M 0.82% 46

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hartline Investment Corp's NVO Position: Q3 2024 in Review

Hartline Investment Corp sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 1,620 shares — an estimated $231K sold.

Hartline Investment Corp first reported a position in NVO in Q2 2013 and held it in 22 quarters. The position peaked at $5.83M in Q4 2015. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Hartline Investment Corp reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Hartline Investment Corp sold 1,620 Novo Nordisk shares in Q3 2024, an estimated $231K.
  • Hartline Investment Corp first reported a position in Novo Nordisk in Q2 2013 and held it in 22 quarters.
  • Hartline Investment Corp's Novo Nordisk position peaked at $5.83M in Q4 2015.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Hartline Investment Corp's 13F filing for Q3 2024, filed 5 Nov 2024.